ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Alendronic Acid → N-(N-(N-(4,4-bis(diallylphosphoryl)butyryl)glycyl)L-phenylalanyl)glycine

HRID 39266
印刷

反応式

HRID 39266 の反応式
[CH2:1](CN)[CH2:2][C:3]([P:9]([OH:12])(O)=O)([P:5](O)(O)=[O:6])O.CCN([CH:21]([CH3:23])[CH3:22])C(C)C.CN(C(ON1N=NC2C=C[CH:37]=[CH:38][C:33]1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[NH2:48][CH2:49][C:50]([NH:52][C@H:53]([C:61]([NH:63][CH2:64][C:65]([OH:67])=[O:66])=[O:62])[CH2:54][C:55]1[CH:60]=[CH:59][CH:58]=[CH:57][CH:56]=1)=[O:51].CN([CH:71]=[O:72])C>C(OCC)(=O)C>[CH2:61]([P:5]([CH:3]([P:9]([CH2:23][CH:21]=[CH2:22])([CH2:33][CH:38]=[CH2:37])=[O:12])[CH2:2][CH2:1][C:71]([NH:48][CH2:49][C:50]([NH:52][C@H:53]([C:61]([NH:63][CH2:64][C:65]([OH:67])=[O:66])=[O:62])[CH2:54][C:55]1[CH:60]=[CH:59][CH:58]=[CH:57][CH:56]=1)=[O:51])=[O:72])([CH2:60][CH:55]=[CH2:56])=[O:6])[CH:53]=[CH2:54]
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

7

反応物 5

HCID 2088Alendronic AcidHCID 6228DimethylformamideHCID 81531DiisopropylethylamineHCID 2733084Methanaminium, N-((1H-benzotriazol-1-yloxy)(dimethylamino)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 6992441Glycyl-phenylalanyl-glycine

生成物 1

HCID 87302179
N-(N-(N-(4,4-bis(diallylphosphoryl)butyryl)glycyl)L-phenylalanyl)glycine

試薬・触媒・溶媒 1

HCID 8857Ethyl Acetate溶媒

反応条件

温度
0 °C

実験手順

To a solution of bisphosphonate 8 (400 mg, 0.98 mmol) in DMF (5 mL) at 0° C. was added DIEA (341 μL, 1.96 mmol) and HBTU (372 mg, 0.98 mmol). After stirring for 10 min at 0° C., the resulting activated ester solution was added to crude tripeptide 75 (0.98 mmol) and stirring was pursued for 2.5 h at 0° C. The reaction mixture was diluted with ethyl acetate, washed with H2O, 1N HCl solution, saturated NaHCO3 solution and saturated NaCl solution. The organic layer was dried over MgSO4, filtered and concentrated to dryness. The crude product was purified by silica gel chromatography on a Biotage™ flash chromatography system using a gradient of 0-10% methanol in ethyl acetate. Compound 76 was obtained as a colorless gum (652 mg, 92%). 1H NMR (400 MHz, CDCl3) δ 1.44 (s, 9H), 2.22-2.37 (m, 2H), 2.57 (t, J=6.4 Hz, 2H), 2.62 (tt, J=23.9, 7.0 Hz, 1H), 3.03-3.09 (m, 1H), 3.14-3.20 (m, 1H), 3.77-3.93 (m, 4H), 4.58-4.63 (m, 8H), 4.66-4.71 (m, 1H), 5.21-5.26 (m, 4H), 5.33-5.41 (m, 4H), 5.89-5.99 (m, 4H), 6.58-6.66 (m, 2H), 7.09 (d, J=8.2, 1H), 7.19-7.23 (m, 3H), 7.27-7.30 (m, 2H).

後処理

  1. stirringstirring
  2. waitwas pursued for 2.5 h at 0° C
  3. washwashed with H2O, 1N HCl solution, saturated NaHCO3 solution and saturated NaCl solution
  4. dry with materialThe organic layer was dried over MgSO4
  5. filtrationfiltered
  6. concentrationconcentrated to dryness
  7. customThe crude product was purified by silica gel chromatography on a Biotage™ flash chromatography system

出典と根拠

ORDレコード
ord-ff1ade8889734ef28619030a99ed52be
出典データセット
uspto-grants-2013_09
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08524691B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート